Molecular Formula | C15H12N2O3 |
Molar Mass | 268.27 |
Density | 1.315±0.06 g/cm3(Predicted) |
Boling Point | 482.1±45.0 °C(Predicted) |
pKa | -0.47±0.10(Predicted) |
Storage Condition | 2-8°C |
biological activity | TMBIM6 angiist -1 is a potential TMBIM6 antagonist that inhibits the binding of TMBIM6 to mTORC2, mTORC2 activity is reduced, regulating the release of Ca2 from tmbmi 6. |
Cell Line: | HT1080, MCF7, MDA-MB-2341 and SKBR3 cells. WT and TMBIM6 KO HT1080 cells. |
Concentration: | 0.5-10 μM. 0, 2, 5 μM. |
Incubation Time: | 3 days. |
Result: | Inhibited cell viability. Downregulated the protein levels of AKT-pS473. Impaired cell-driven tumor growth. |
Animal Model: | Six- to eight-week BklNbt:BALB/c/nu/nu old mice (HT1080 and MDA-MB-231 cells). |
Dosage: | 1 mg/kg. |
Administration: | IP 5 days per week during 25 days. |